These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 26214651

  • 21. Antiplatelet therapy in patients with coronary stent undergoing urologic surgery: is it still no man's land?
    Naspro R, Rossini R, Musumeci G, Gadda F, Pozzo LF.
    Eur Urol; 2013 Jul; 64(1):101-5. PubMed ID: 23428067
    [No Abstract] [Full Text] [Related]

  • 22. Shorter (≤6 months) versus longer (≥12 months) duration dual antiplatelet therapy after drug eluting stents: a meta-analysis of randomized clinical trials.
    Pandit A, Giri S, Hakim FA, Fortuin FD.
    Catheter Cardiovasc Interv; 2015 Jan 01; 85(1):34-40. PubMed ID: 24753084
    [Abstract] [Full Text] [Related]

  • 23. Dual antiplatelet therapy after drug-eluting stents: defining the proper duration.
    Park SJ, Kang SM, Park DW.
    Coron Artery Dis; 2014 Jan 01; 25(1):83-9. PubMed ID: 24322887
    [Abstract] [Full Text] [Related]

  • 24. [Perioperative management and postoperative complication rates of patients on dual antiplatelet therapies after coronary drug eluting stent implantation].
    Komiya R, Kamintani K, Kubo E, Hattori M, Kataoka H, Iwase Y, Miyoshi H, Minami M, Kato S, Arai R, Yoshida H.
    Masui; 2014 Jun 01; 63(6):629-35. PubMed ID: 24979851
    [Abstract] [Full Text] [Related]

  • 25. Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should be continued for more than one year and preferably indefinitely.
    Chhatriwalla AK, Bhatt DL.
    Circ Cardiovasc Interv; 2008 Dec 01; 1(3):217-25. PubMed ID: 20031681
    [No Abstract] [Full Text] [Related]

  • 26. Thrombotic and bleeding events after coronary stenting according to clopidogrel and aspirin platelet reactivity: VerifyNow French Registry (VERIFRENCHY).
    Rangé G, Yayehd K, Belle L, Thuaire C, Richard P, Cazaux P, Barbou F, Köning R, Chassaing S, Teiger E, Berthier R, Decomis MP, Claudel JP, Delarche N, Brunel P, De Poli F, Dupouy P, Beygui F, Albert F, Collet JP, Montalescot G, VERIFRENCHY investigators.
    Arch Cardiovasc Dis; 2014 Apr 01; 107(4):225-35. PubMed ID: 24794216
    [Abstract] [Full Text] [Related]

  • 27. Ticlopidine and aspirin therapy following implantation of coronary artery stents.
    Hobson AG, Sowinski KM.
    Ann Pharmacother; 1997 Jun 01; 31(6):770-2. PubMed ID: 9184720
    [Abstract] [Full Text] [Related]

  • 28. High clopidogrel dose in patients with chronic kidney disease having clopidogrel resistance after percutaneous coronary intervention.
    Liang J, Wang Z, Shi D, Liu Y, Zhao Y, Han H, Li Y, Liu W, Zhang L, Yang L, Zhou Y.
    Angiology; 2015 Apr 01; 66(4):319-25. PubMed ID: 24913197
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Antiplatelet therapy management in patients with coronary stent undergoing vascular surgery.
    Bozzani A, Ferlini M, Rossini R, Musumeci G, Arici V, Bramucci E, Setacci C.
    J Cardiovasc Surg (Torino); 2015 Aug 01; 56(4):681-3. PubMed ID: 25008060
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Are at least 12 months of dual antiplatelet therapy needed for all patients with drug-eluting stents? All patients with drug-eluting stents need at least 12 months of dual antiplatelet therapy.
    Brener SJ.
    Circulation; 2015 Jun 02; 131(22):2001-9; discussion 2009. PubMed ID: 26034082
    [No Abstract] [Full Text] [Related]

  • 33. Which patients receiving warfarin can be treated safely with a drug-eluting stent?
    Ryding AD, Banning AP.
    Heart; 2008 Mar 02; 94(3):275-7. PubMed ID: 18276815
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Drug-eluting stents can increase the risk of late stent thrombosis].
    Skyttberg N, Linder R, Carlsson J.
    Lakartidningen; 2008 Mar 02; 103(39):2845-7. PubMed ID: 17128916
    [No Abstract] [Full Text] [Related]

  • 36. No benefit to prolonged dual antiplatelet therapy after drug-eluting stent placement.
    Ebell MH.
    Am Fam Physician; 2014 Oct 01; 90(7):502. PubMed ID: 25369632
    [No Abstract] [Full Text] [Related]

  • 37. Non-cardiac surgery in patients with drug eluting stents: considerations on antiplatelet therapy.
    Manoria P, Bhandari S.
    Indian Heart J; 2007 Oct 01; 59(4):378-81. PubMed ID: 19126949
    [No Abstract] [Full Text] [Related]

  • 38. Very late thrombosis after implantation of sirolimus eluting stent.
    Karvouni E, Korovesis S, Katritsis DG.
    Heart; 2005 Jun 01; 91(6):e45. PubMed ID: 15894746
    [Abstract] [Full Text] [Related]

  • 39. Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Chen KY, Rha SW, Li YJ, Poddar KL, Jin Z, Minami Y, Wang L, Kim EJ, Park CG, Seo HS, Oh DJ, Jeong MH, Ahn YK, Hong TJ, Kim YJ, Hur SH, Seong IW, Chae JK, Cho MC, Bae JH, Choi DH, Jang YS, Chae IH, Kim CJ, Yoon JH, Chung WS, Seung KB, Park SJ, Korea Acute Myocardial Infarction Registry Investigators.
    Circulation; 2009 Jun 30; 119(25):3207-14. PubMed ID: 19528339
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.